Tue, Nov 26, 2024 12:43 PM
SMS Lifescience Standalone September 2024 Net Sales at Rs 78.50 crore
A Flip by Shubhangi Gupta
Dr. Reddy's Laboratories Ltd., along with its subsidiaries, announced the launch of Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma. Toripalimab is a New Biological Entity (NBE). It is the only immuno-oncology drug approved by various regulatory authorities around the world.
Open Flip
📈 Amid mixed global cues, benchmark indices started on a flat note today. 📊 At 9:16 AM, the Sensex gained 57.86 points or 0.07% at 80,291.94 and the Nifty was up 10.80 points or 0.04% at 24,285.70. 📢Adani Enterprises (⬆️2.21%), Colgate (⬆️1.91%) and HDFC Life (⬆️1.38%) appeared as the top performers on the Nifty50 at open.
Open Flip
Goldman Sachs maintains a 'Buy' rating on Marico with a target price of ₹720, implying a 10% upside, citing the company's ability to navigate the current tough environment, with Parachute and Saffola brands showing strong growth. Goldman Sachs revises earnings estimates downward due to copra inflation, but Marico's CEO is optimistic about digital growth and double-digit revenue growth in H2 FY25.
Open Flip
